Fatal Dermatological Squeal Following Depot Medroxyprogesterone Acetate (Dmpa) Administration: A Catastrophic Hypersensitivity Case Report

Aisha Rehma Siddiqui

Liaqat memorial Hospital Jamshoro Sindh, Pakistan

Biography :

Dr. Aisha Rehma Siddiqui MD, an ECFMG certified postgraduate trainee currently working in a tertiary care hospital in Pakistan. I have research experience and have published 10 papers in renowned journals.

Abstract :

The use of depot progesterone as a contraceptive every three months by a considerable number of Women has raised concerns regarding the potential for hormones and chemicals to trigger fatal immune Responses resulting in skin reactions. The focus of our case report is a 25-year-old woman who suffered a fatal dermatological con­dition after using this contraceptive. It is noteworthy that this specific Condition has not been documented in medical literature before.